• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用化学修饰壳聚糖的受体介导基因递送。

Receptor-mediated gene delivery using chemically modified chitosan.

作者信息

Kim T H, Jiang H L, Nah J W, Cho M H, Akaike T, Cho C S

机构信息

School of Agricultural Biotechnology, Seoul National University, Seoul 151-921, Korea.

出版信息

Biomed Mater. 2007 Sep;2(3):S95-100. doi: 10.1088/1748-6041/2/3/S02. Epub 2007 Jul 30.

DOI:10.1088/1748-6041/2/3/S02
PMID:18458467
Abstract

Chitosan has been investigated as a non-viral vector because it has several advantages such as biocompatibility, biodegradability and low toxicity with high cationic potential. However, the low specificity and low transfection efficiency of chitosan need to be solved prior to clinical application. In this paper, we focused on the galactose or mannose ligand modification of chitosan for enhancement of cell specificity and transfection efficiency via receptor-mediated endocytosis in vitro and in vivo.

摘要

壳聚糖已被作为一种非病毒载体进行研究,因为它具有生物相容性、生物可降解性以及低毒性和高阳离子潜力等多种优点。然而,壳聚糖的低特异性和低转染效率在临床应用前需要解决。在本文中,我们聚焦于壳聚糖的半乳糖或甘露糖配体修饰,以通过体外和体内受体介导的内吞作用提高细胞特异性和转染效率。

相似文献

1
Receptor-mediated gene delivery using chemically modified chitosan.使用化学修饰壳聚糖的受体介导基因递送。
Biomed Mater. 2007 Sep;2(3):S95-100. doi: 10.1088/1748-6041/2/3/S02. Epub 2007 Jul 30.
2
Efficient gene delivery using chitosan-polyethylenimine hybrid systems.使用壳聚糖-聚乙烯亚胺混合体系进行高效基因传递
Biomed Mater. 2008 Jun;3(2):025013. doi: 10.1088/1748-6041/3/2/025013. Epub 2008 May 14.
3
Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting.甘露糖基化壳聚糖接枝聚乙烯亚胺作为一种用于靶向Raw 264.7细胞的基因载体。
Int J Pharm. 2009 Jun 22;375(1-2):133-9. doi: 10.1016/j.ijpharm.2009.03.033. Epub 2009 Apr 5.
4
Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting.半乳糖基化聚乙二醇-壳聚糖-接枝-聚乙烯亚胺作为一种用于肝细胞靶向的基因载体。
J Control Release. 2008 Oct 21;131(2):150-7. doi: 10.1016/j.jconrel.2008.07.029. Epub 2008 Jul 26.
5
Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone.通过将细胞内缓冲部分引入壳聚糖主链来改善壳聚糖介导的基因转移。
Acta Biomater. 2009 Oct;5(8):2995-3006. doi: 10.1016/j.actbio.2009.04.021. Epub 2009 May 4.
6
Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery.用于肿瘤靶向基因递送的叶酸-聚乙二醇接枝超支化聚乙烯亚胺的合成与表征
Biochem Biophys Res Commun. 2008 Mar 21;367(4):874-80. doi: 10.1016/j.bbrc.2008.01.024. Epub 2008 Jan 15.
7
Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.以水溶性壳聚糖作为基因载体制备的半乳糖基化壳聚糖/DNA纳米粒。
Biomaterials. 2004 Aug;25(17):3783-92. doi: 10.1016/j.biomaterials.2003.10.063.
8
Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages.通过DNA/甘露糖基化壳聚糖复合物将基因导入小鼠腹腔巨噬细胞。
Biotechnol Lett. 2006 Jun;28(11):815-21. doi: 10.1007/s10529-006-9006-x. Epub 2006 May 31.
9
Preparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cells.壳聚糖-DNA-FAP-B 纳米粒的制备及评价——作为一种新型非病毒载体向肺上皮细胞递呈基因
Int J Pharm. 2011 May 16;409(1-2):307-13. doi: 10.1016/j.ijpharm.2011.02.043. Epub 2011 Feb 26.
10
Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.通过半乳糖基化壳聚糖载体将寡核苷酸和质粒DNA靶向递送至肝细胞。
Eur J Pharm Biopharm. 2005 Aug;60(3):327-34. doi: 10.1016/j.ejpb.2005.02.011.

引用本文的文献

1
Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.桦木酸半乳糖化壳聚糖纳米粒的制备及其对肝纤维化的作用。
Int J Nanomedicine. 2022 Sep 14;17:4195-4210. doi: 10.2147/IJN.S373430. eCollection 2022.
2
Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.鼻腔内接种甘露糖化壳聚糖配方 DNA 疫苗可在小鼠肺部诱导强烈的 IgA 和细胞应答,并改善对肺部分枝杆菌挑战的保护。
Front Cell Infect Microbiol. 2017 Oct 16;7:445. doi: 10.3389/fcimb.2017.00445. eCollection 2017.
3
Preparation and functional studies of hydroxyethyl chitosan nanoparticles loaded with anti-human death receptor 5 single-chain antibody.
载抗人死亡受体 5 单链抗体羟乙基壳聚糖纳米粒的制备及功能研究。
Onco Targets Ther. 2014 May 21;7:779-87. doi: 10.2147/OTT.S59872. eCollection 2014.
4
Chitosans for delivery of nucleic acids.壳聚糖用于核酸递送。
Adv Drug Deliv Rev. 2013 Aug;65(9):1234-70. doi: 10.1016/j.addr.2013.07.005. Epub 2013 Jul 18.
5
Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin.载阿霉素半乳糖化低相对分子质量壳聚糖纳米粒的制备及体外性质考察。
AAPS PharmSciTech. 2010 Jun;11(2):686-97. doi: 10.1208/s12249-010-9422-z. Epub 2010 Apr 23.
6
Comparison on in vitro characterization of fucospheres and chitosan microspheres encapsulated plasmid DNA (pGM-CSF): formulation design and release characteristics.藻酸盐微球和壳聚糖微球包封质粒 DNA(pGM-CSF)的体外特性比较: 制剂设计和释放特性。
AAPS PharmSciTech. 2009;10(4):1193-9. doi: 10.1208/s12249-009-9324-0. Epub 2009 Oct 27.